Neuropsychological Functioning and Cerebral Perfusion Post Carotid Endarterectomy

February 15, 2021 updated by: Ali AbuRahma, CAMC Health System

Relationship Between Neuropsychological Functioning and Cerebral Perfusion in Patients Undergoing Carotid Endarterectomy

The study aims to investigate the relationship between neuropsychological functioning and brain perfusion in patients undergoing carotid endarterectomy and control patients undergoing other peripheral vascular procedures.

Study Overview

Status

Withdrawn

Detailed Description

Carotid endarterectomy (CEA) is a vascular surgical procedure that is aimed at reducing accumulated cholesterol and fats in carotid arteries. While some research indicates that CEA is associated with improvements in neuropsychological functioning, other studies have identified deficits in neuropsychological functioning following CEA. The factors associated with these different outcomes are unclear. Identification of the factors that mediate post-CEA neuropsychological functioning outcomes may allow for the development of interventions that would improve such outcomes. Recent research has identified a relationship between post-CEA neuropsychological deficits, and cerebral blood flow in certain areas of the brain, with some indication that brain cell loss following CEA may be a key factor. The proposed study will explore changes in cerebral blood flow through the use of diffusion-weighted magnetic resonance images (DW-MRI) to investigate the relationship between neuropsychological functioning and brain perfusion in 70 CEA patients and to compare neuropsychological functioning of the CEA patients to a control group of 30 patients undergoing other peripheral vascular surgical procedures. Patients' neuropsychological functioning will be assessed pre, post and six months after the CEA or peripheral vascular surgery. Additionally DW-MRI will be assessed pre and post surgery for the patients undergoing CEA.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Virginia
      • Charleston, West Virginia, United States, 25304
        • Charleston Area Medical Center Vascular Center of Excellence

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

70 patients undergoing elective carotid endarterectomy and 30 patients undergoing other peripheral vascular surgical procedures

Description

Inclusion Criteria:

  • Patients undergoing elective carotid endarterectomy or other peripheral vascular surgical procedures.
  • Ages 40-90

Exclusion Criteria:

  1. History of Substance Use:

    History of cocaine use within the past 12 months. Tetrahydrocannabinol use within the past 12 months.

  2. Conditions that affect brain MRI/contraindications for MRI:

    Diagnosis of HIV. History of any traumatic brain injury. History or current diagnosis with any form of brain tumor. Current normal pressure hydrocephalus. Patients with any implanted metallic medical device, or non-removable metallic material in their body

  3. Conditions that affect neuropsychological assessment:

    Diagnosis with Attention Deficit/Hyperactivity Disorder. Current major depressive episode. Current manic episode. Current psychotic episode. Diagnosis with any developmental disorder. Diagnosis with any form of dementia (MMSE<24). A score higher than 3 on the Modified Rankin Scale indicating a major stroke.

  4. General Contraindications:

Diagnosis with or history of any medical condition that, based on reasonable clinical judgment, would clinically contraindicate the patient undergoing any of the study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Carotid Endarterectomy (CEA)
70 participants undergoing CEA
Other Peripheral Vascular Surgery
30 participants undergoing other peripheral vascular surgical procedures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
A battery of eight neuropsychological tests
Time Frame: 7 days before surgery, 1-7 days after surgery and 6 months after surgery
7 days before surgery, 1-7 days after surgery and 6 months after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Diffusion Weighted Magnetic Resonance Imaging
Time Frame: 7 days before surgery, 1-7 days after surgery
7 days before surgery, 1-7 days after surgery

Other Outcome Measures

Outcome Measure
Time Frame
Short Form-36
Time Frame: 7 days before surgery, 1-7 days after surgery and 6 months follow-up
7 days before surgery, 1-7 days after surgery and 6 months follow-up
Beck Depression Inventory II
Time Frame: 7 days before surgery, 1-7 days after surgery and 6 months after surgery
7 days before surgery, 1-7 days after surgery and 6 months after surgery
State-Trait Anxiety Inventory
Time Frame: 7 days before surgery, 1-7 days after surgery and 6 months after surgery
7 days before surgery, 1-7 days after surgery and 6 months after surgery
An 11-point Numeric Pain Intensity Scale
Time Frame: 7 days before surgery, 1-7 days after surgery and 6 months after surgery
7 days before surgery, 1-7 days after surgery and 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali AbuRahma, MD, Charleston Area Medical Center Vascular Center of Excellence

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 22, 2013

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

January 1, 2020

Study Registration Dates

First Submitted

November 27, 2013

First Submitted That Met QC Criteria

February 15, 2021

First Posted (Actual)

February 18, 2021

Study Record Updates

Last Update Posted (Actual)

February 18, 2021

Last Update Submitted That Met QC Criteria

February 15, 2021

Last Verified

January 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carotid Artery Stenosis

3
Subscribe